Document is current
Any future updates will be listed below
-
Authors
Sener, Ugur https://orcid.org/0000-0002-3919-7408
Uhm, Joon
Haddad, Tufia https://orcid.org/0000-0001-8226-3581
Pritchett, Joshua https://orcid.org/0000-0001-6139-5526
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR002377)
- License Information
-
More Information
Article History
Accepted: 21 July 2024
First Online: 31 July 2024
Declarations
:
: Joshua Pritchett has nothing to disclose. Joon Uhm has nothing to disclose. Ugur Sener has served on an advisory board for Servier Pharmaceuticals LLC; unrelated to this work. Tufa Haddad has received research grant funding from Takeda Oncology (Institutional) and served on an advisory board for Puma Biotechnology (no personal compensation); both are unrelated to this work.
: Joshua Pritchett has nothing to disclose. Joon Uhm has nothing to disclose. Ugur Sener has served on an advisory board for Servier Pharmaceuticals LLC; unrelated to this work. Tufa Haddad has received research grant funding from Takeda Oncology (Institutional) and served on an advisory board for Puma Biotechnology (no personal compensation); both are unrelated to this work.
